The Niche Assessment Program for HHS SBIR/STTR Phase I Awardees is Now Accepting Applications!

national heart, lung and blood institute logo image

Office of Translational Alliances and Coordination

Market Analyses For HHS SBIR/STTR Phase I Awardees - Niche Assessment Program

APPLY today through

NIH SBIR/STTR Setup Form

The Niche Assessment Program provides market insight and data that can be used to help small businesses strategically position their technology in the marketplace. The results of this program can help small businesses develop their commercialization plans for their Phase II application, and be exposed to potential partners. 

Technology Niche Analyses® (TNA®) are provided by Foresight, for one hundred and fifty (150), HHS SBIR/STTR Phase I awardees. These analyses assess potential applications for a technology and then for one viable application, it provides an assessment of the:

  1. Needs and concerns of end-users;
  2. Competing technologies and competing products;
  3. Competitive advantage of the SBIR/STTR-developed technology;
  4. Market size and potential market share (may include national and/or global markets);
  5. Barriers to market entry (may include but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.);
  6. Market drivers;
  7. Status of market and industry trends;
  8. Potential customers, licensees, investors, or other commercialization partners; and,
  9. The price customers are likely to pay.

Each participant receives an in-depth report of Foresight's findings. Oftentimes the small businesses can use this information in their commercialization plans which are part of their Phase II applications.

All active HHS (NIH, CDC, FDA) SBIR/STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract) are eligible to apply. Registration is on a first come, first serve basis!

For more information, please visitNiche Assessment Program

Notice: NOT-OD-17-128